Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA.
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Soc Psychiatry Psychiatr Epidemiol. 2023 Jul;58(7):1099-1108. doi: 10.1007/s00127-023-02453-9. Epub 2023 Mar 14.
The COVID-19 pandemic has had wide-ranging impacts on mental health, however, less is known about predictors of mental health outcomes among adults who have experienced a COVID-19 diagnosis. We examined the intersection of demographic, economic, and illness-related predictors of depressive and anxiety symptoms within a population-based sample of adults diagnosed with COVID-19 in the U.S. state of Michigan early in the pandemic.
Data were from a population-based survey of Michigan adults who experienced a COVID-19 diagnosis prior to August 1, 2020 (N = 1087). We used weighted prevalence estimates and multinomial logistic regression to examine associations between mental health outcomes (depressive symptoms, anxiety symptoms, and comorbid depressive/anxiety symptoms) and demographic characteristics, pandemic-associated changes in accessing basic needs (accessing food/clean water and paying important bills), self-reported COVID-19 symptom severity, and symptom duration.
Relative risks for experiencing poor mental health outcomes varied by sex, age, race/ethnicity, and income. In adjusted models, experiencing a change in accessing basic needs associated with the pandemic was associated with higher relative risks for anxiety and comorbid anxiety/depressive symptoms. Worse COVID-19 symptom severity was associated with a higher burden of comorbid depressive/anxiety symptoms. "Long COVID" (symptom duration greater than 60 days) was associated with all outcomes.
Adults diagnosed with COVID-19 may face overlapping risk factors for poor mental health outcomes, including pandemic-associated disruptions to household and economic wellbeing, as well as factors related to COVID-19 symptom severity and duration. An integrated approach to treating depressive/anxiety symptoms among COVID-19 survivors is warranted.
新冠疫情对心理健康产生了广泛影响,但对于经历过新冠诊断的成年人的心理健康结果的预测因素知之甚少。我们在美国密歇根州的新冠疫情早期,在一个基于人群的新冠确诊成年人样本中,研究了人口统计学、经济和与疾病相关的预测因素与抑郁和焦虑症状之间的交叉。
数据来自一项基于人群的密歇根成年人调查,他们在 2020 年 8 月 1 日之前经历过新冠诊断(N=1087)。我们使用加权患病率估计和多项逻辑回归来研究心理健康结果(抑郁症状、焦虑症状和共患抑郁/焦虑症状)与人口统计学特征、与大流行相关的获取基本需求的变化(获取食物/清洁水和支付重要账单)、自我报告的新冠症状严重程度和症状持续时间之间的关联。
经历不良心理健康结果的相对风险因性别、年龄、种族/族裔和收入而异。在调整后的模型中,经历与大流行相关的获取基本需求的变化与焦虑和共患焦虑/抑郁症状的相对风险增加有关。更严重的新冠症状严重程度与共患抑郁/焦虑症状的负担增加有关。“长新冠”(症状持续时间超过 60 天)与所有结果有关。
被诊断为新冠的成年人可能面临重叠的不良心理健康结果的风险因素,包括与大流行相关的家庭和经济福祉中断,以及与新冠症状严重程度和持续时间相关的因素。需要采取综合方法来治疗新冠幸存者的抑郁/焦虑症状。